Aujla AS - Search Results

1

Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors.

Aly R, Aujla AS, Gupta S, Gupta R, Gupta S, Kalathil S. Aly R, et al. Among authors: aujla as. World J Oncol. 2020 Oct;11(5):183-187. doi: 10.14740/wjon1325. Epub 2020 Oct 15. World J Oncol. 2020. PMID: 33117461 Free PMC article. Review.

2

T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches.

Colon Ramos A, Tarekegn K, Aujla A, Garcia de de Jesus K, Gupta S. Colon Ramos A, et al. Cureus. 2021 Feb 9;13(2):e13237. doi: 10.7759/cureus.13237. Cureus. 2021. PMID: 33728186 Free PMC article. Review.

3

Thrombotic thrombocytopenic purpura possibly triggered by Graves' disease.

Chitnis SD, Mene-Afejuku TO, Aujla A, Shady A, Gil GS, Cativo EH, Popescu-Martinez A. Chitnis SD, et al. Oxf Med Case Reports. 2017 Oct 24;2017(10):omx057. doi: 10.1093/omcr/omx057. eCollection 2017 Oct. Oxf Med Case Reports. 2017. PMID: 29744115 Free PMC article.

4

Lineage switch from T-cell lymphoblastic leukemia/lymphoma to acute myeloid leukemia and back to T-cell lymphoblastic leukemia/lymphoma in a patient diagnosed during pregnancy.

Aujla A, Hanmantgad M, Islam H, Shakil F, Liu D, Seiter K. Aujla A, et al. Stem Cell Investig. 2019 May 24;6:12. doi: 10.21037/sci.2019.05.02. eCollection 2019. Stem Cell Investig. 2019. PMID: 31231669 Free PMC article.

5

Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.

Dutta D, Aujla A, Knoll BM, Lim SH. Dutta D, et al. Br J Haematol. 2020 Feb;188(4):488-493. doi: 10.1111/bjh.16273. Epub 2019 Nov 6. Br J Haematol. 2020. PMID: 31693163 Free article. Review.

6

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Aujla A, Aujla R, Liu D. Aujla A, et al. Biomark Res. 2019 Apr 11;7:9. doi: 10.1186/s40364-019-0160-4. eCollection 2019. Biomark Res. 2019. PMID: 31011424 Free PMC article. Review.

7

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms.

Aujla A, Linder K, Iragavarapu C, Karass M, Liu D. Aujla A, et al. Biomark Res. 2018 Sep 26;6:29. doi: 10.1186/s40364-018-0142-y. eCollection 2018. Biomark Res. 2018. PMID: 30275952 Free PMC article. Review.

8

Procalcitonin as a biomarker to differentiate bacterial infections from engraftment syndrome following autologous hematopoietic stem cell transplantation for multiple myeloma.

Knoll BM, Ahmed J, Karass M, Aujla A, McHale P, Kretschmer P, Mazumder A, Seiter K, Ahmed T, Lim SH. Knoll BM, et al. Am J Hematol. 2019 Mar;94(3):E74-E76. doi: 10.1002/ajh.25378. Epub 2018 Dec 31. Am J Hematol. 2019. PMID: 30549311 Free PMC article. No abstract available.

9

Late-onset fever and engraftment syndrome following autologous stem cell transplant: Impact on resource utilization.

Ahmed J, Karass M, Aujla A, McHale P, Kretschmer P, Mazumder A, Seiter K, Ahmed T, Lim SH, Knoll BM. Ahmed J, et al. Am J Hematol. 2018 Oct;93(10):E336-E338. doi: 10.1002/ajh.25221. Epub 2018 Aug 14. Am J Hematol. 2018. PMID: 30027614 Free PMC article. No abstract available.

10

Cardiovascular Sequelae of Sickle Cell Disease.

Aujla A, Dutta D, Amar S, Frishman W, Lim SH. Aujla A, et al. Cardiol Rev. 2020 Jan/Feb;28(1):10-13. doi: 10.1097/CRD.0000000000000264. Cardiol Rev. 2020. PMID: 31804288 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page